Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) - Concepedia

Concepedia

Publication | Open Access

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

DOI Full Paper Access

59

Citations

37

References

2021

Year

Marijo Bilušić, Sheri McMahon, Ravi A. Madan, Fatima Karzai, Yo-Ting Tsai, Renee N. Donahue, Claudia Palena, Caroline Jochéms, Jennifer L. Marté, Charalampos S. Floudas,

Journal for ImmunoTherapy of Cancer

Abstract

NCT03481816.

References

	Year	Citations

Page 1